Journal of Chemical and Pharmaceutical Research (ISSN : 0975-7384)

header
Reach Us reach to JOCPR whatsapp-JOCPR +44 1625708989
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Original Articles: 2016 Vol: 8 Issue: 4

Evaluation of Novel Compound Benzoylphenyl-Indole-Carboxamide Effect on Hyperlipidemic and Hyperglycemic Rat

Abstract

Hyperlipidemia is one of the most risk factors involved in the development of cardiovascular disease. As a consequence of hyperlipidemia treatment, a high demand for new oral antihyperlipidemic drugs is required. The present study was designed to investigate the potential effect of a novel compound N-[4-benzoylphenyl]-1H-indole- 2-carboxamide on diet-induced hyperlipidemic (prepared by mixing cholesterol 0.5%, 0.25 % cholic acid, 20% fat and 2% corn oil with standard powdered animal food for two months) , triton-induced hyperlipidemic (by intraperitoneal injection of Triton WR-1339 250 mg/kg body weight) and alloxan-induced hyperglycemic rats (150 mg/kg body weight injected intraperitoneally). Lipid profiles [Total cholesterol (TC), Triglyceride (TG), Low Density Lipoprotein (LDL) and High Density Lipoprotein (HDL)] in all groups showed significant (p < 0.05) changes (±) before treatment. After 24 hrs of treatment with N-[4-benzoylphenyl]-1H-indole-2-carboxamide (15 mg/kg body weight), significant decrease (p <0.05) in serum cholesterol level 60%, , triglyceride 33-45%, LDL 32% and increase HDL 58% levels. Nevertheless, antihyperlipidemic fenofibrate - used as standard reference - showed parallel results to the novel compound. In addition, body weight of diet-induced hyperlipidemic rats decreased about 20%. On the other hand, the novel compound showed no significant effect on glucose level of hyperglycemic rats. In conclusion, the results indicate that N-[4-benzoylphenyl]-1H-indole-2-carboxamide possesses significant antihyperlipidemic activity and may conserve a promising potential effect in the treatment of hyperlipidemia correlated to heart diseases.